In particular, we recognized Notch ligand DLL1 as the specific molecular target in childhood neuroblastoma and we proposed miRNAs as novel therapeutic tool to attack “DLL1 positive” neuroblastoma [7]. Here, DLL1 is linked to neuroblastoma.